Ampol Profit Surges as Refining Margins Hit Record Highs 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets 
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles 
Bathla Group Hires Administrators as Australia Housing Slump Deepens 
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Nvidia Options Price in $280 Billion Earnings Swing 
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
SK Hynix Shares Fall as Workers Reject Wage Deal 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Add as a preferred source on Google
NEW ORLEANS, April 27, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 7, 2018 to file lead plaintiff applications in a securities class action lawsuit against Henry Schein, Inc. (Nasdaq:HSIC), if they purchased the Company’s securities between March 7, 2013 and February 12, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Henry Schein investors should visit us at https://www.claimsfiler.com/cases/view-henry-schein-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Henry Schein and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 12, 2018, the Federal Trade Commission (“FTC”) disclosed that it had filed a complaint against the Company for violating antitrust regulations through a conspiracy with other dental supply companies agreeing to refuse to offer discounts or service to buying groups representing dental practitioners.
On this news, the price of Henry Schein’s shares plummeted $4.79 per share, or over 6.6%.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
